1. Home
  2. EPIX vs INVE Comparison

EPIX vs INVE Comparison

Compare EPIX & INVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EPIX
  • INVE
  • Stock Information
  • Founded
  • EPIX 2009
  • INVE 1990
  • Country
  • EPIX Canada
  • INVE United States
  • Employees
  • EPIX N/A
  • INVE N/A
  • Industry
  • EPIX Biotechnology: Pharmaceutical Preparations
  • INVE Computer peripheral equipment
  • Sector
  • EPIX Health Care
  • INVE Technology
  • Exchange
  • EPIX Nasdaq
  • INVE Nasdaq
  • Market Cap
  • EPIX 76.8M
  • INVE 82.2M
  • IPO Year
  • EPIX N/A
  • INVE 1997
  • Fundamental
  • Price
  • EPIX $1.72
  • INVE $3.44
  • Analyst Decision
  • EPIX Hold
  • INVE Strong Buy
  • Analyst Count
  • EPIX 3
  • INVE 2
  • Target Price
  • EPIX $2.00
  • INVE $7.25
  • AVG Volume (30 Days)
  • EPIX 253.9K
  • INVE 31.8K
  • Earning Date
  • EPIX 02-11-2025
  • INVE 03-05-2025
  • Dividend Yield
  • EPIX N/A
  • INVE N/A
  • EPS Growth
  • EPIX N/A
  • INVE N/A
  • EPS
  • EPIX N/A
  • INVE 3.10
  • Revenue
  • EPIX N/A
  • INVE $104,217,000.00
  • Revenue This Year
  • EPIX N/A
  • INVE N/A
  • Revenue Next Year
  • EPIX N/A
  • INVE N/A
  • P/E Ratio
  • EPIX N/A
  • INVE $1.13
  • Revenue Growth
  • EPIX N/A
  • INVE 70.57
  • 52 Week Low
  • EPIX $1.40
  • INVE $2.95
  • 52 Week High
  • EPIX $9.92
  • INVE $9.24
  • Technical
  • Relative Strength Index (RSI)
  • EPIX 47.93
  • INVE 40.36
  • Support Level
  • EPIX $1.69
  • INVE $3.41
  • Resistance Level
  • EPIX $1.83
  • INVE $3.67
  • Average True Range (ATR)
  • EPIX 0.07
  • INVE 0.19
  • MACD
  • EPIX 0.01
  • INVE 0.01
  • Stochastic Oscillator
  • EPIX 57.69
  • INVE 12.20

About EPIX ESSA Pharma Inc.

ESSA Pharma Inc is a pharmaceutical company. The company is focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It is developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival.

About INVE Identiv Inc.

Identiv Inc is a security technology company. It secures and manages access to physical places, things, and information. The company has two reportable segments namely the Premises segment which includes solutions to address the premises security market for government and enterprise, including access control, video surveillance, analytics, customer experience, and other applications. Its Identity segment includes products and solutions enabling secure access to information serving the logical access and cyber security market and protecting assets and objects in the IoT with RFID. Geographically, it generates maximum revenue from the Americas and also has a presence in Europe and the Middle East, and Asia-Pacific. The company derives the majority of revenue from the Identity segment.

Share on Social Networks: